POMDOCTOR Ltd (POM) Form 6-K — Oct 9, 2026

POMDOCTOR LIMITED received a Nasdaq staff delisting determination on October 6, 2026 after its ADSs closed below $1.00 per share for 30 consecutive business days from August 24 through October 5, 2026, violating the minimum bid price rule. The company is ineligible for the usual 180-day compliance period because it executed a 1-for-18 reverse stock split on June 22, 2026, within the prior one-year window. Absent an appeal, trading would be suspended at the open on October 15, 2026. POMDOCTOR says it will timely request a Nasdaq Hearings Panel appeal by the October 13, 2026 deadline, which stays the suspension and Form 25-NSE filing while pending.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.